# African Cancer Genome: GMD

> **NCT05754658** · — · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 1500 (estimated)

## Conditions studied

- Breast Cancer
- Prostate Cancer

## Interventions

- **OTHER:** Standard of Care
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT05754658
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754658, "African Cancer Genome: GMD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05754658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*